UCB
Beyond's analysis on UCB
- — UCB’s Top Workplace award coincides with a $2 billion Georgia biomanufacturing investment, highlighting talent attraction and regional economic impact
- — Antengene secures $60 million upfront payment from UCB to advance its drug pipeline